NCT00144677View on ClinicalTrials.gov

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaMyelodysplastic SyndromesNon-Hodgkin's LymphomaHodgkin's Disease
Interventions
DRUG

sirolimus

DRUG

tacrolimus

Trial Locations (1)

02115

Dana-Farber Cancer Center, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT00144677 - Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation | Biotech Hunter | Biotech Hunter